The web search results mention AI's role in TB detection and deployment in multiple countries, but none of the provided evidence sources specifically corroborate the claim that AI is powering a revolution in over 22 countries where the Global Fund invests in TB programs. The evidence is suggestive but lacks the specific corroboration needed for a higher verdict.

The web search results discuss the 'undiagnosed burden' of TB and LTBI, but none of the provided evidence sources quantify this burden as 'Almost 2.5 million people' remaining undiagnosed. The evidence confirms the existence of an undiagnosed burden but does not confirm the specific figure.

The evidence provides general information about TB care pathways and community health workers in India (Arunachal Pradesh), but there is no specific evidence from the provided sources confirming that Indonesia has 'totally redesigned its approach' or shifted treatment initiation to 'more than 460 local "puskesmas"'.

Multiple web search results mention that a 'quarter of the global population' has TB, but none of the provided evidence sources explicitly state the figure '20% of the global population have latent tuberculosis infection' as a confirmed statistic. The evidence points to the existence of LTBI but does not confirm the specific percentage.

The evidence confirms that the BCG vaccine is the vaccine available against TB and that new vaccines are anticipated, but none of the provided sources specify a target availability date of 'around 2029' for a new TB vaccine.

The evidence confirms that the Global Fund is an international financing organization for TB and that funding levels are discussed in relation to TB programs. However, none of the provided sources explicitly state that the 'Global Fund model gives countries the power to determine how funding should be prioritized and spent' in a definitive manner, although the context implies significant national input.